Wide-Area Transepithelial Tissue Sampling with Computer-Assisted 3D Analysis (WATS3D) - (0578)

Cigna considers WATS3D experimental, investigational, or unproven and does not cover its use for detection or surveillance of Barrett’s esophagus (CPTs 88104, 88112, 88305, 88312, 88361 are listed as noncovered when used for WATS3D). Claims must be submitted with covered diagnosis/procedure codes using the most appropriate current codes or they will be denied, and providers should confirm plan-specific benefits and applicable Medicare LCD/NCD guidance.

"None — The use of wide-area transepithelial tissue sampling with computer-assisted three-dimensional (3D) analysis (WATS3D) is considered experimental, investigational or unproven."

Sign up to see full coverage criteria, indications, and limitations.